Health
Common diabetes drug can reduce risk of major heart issues – TheHealthSite
SGLT2 inhibitors prescribed for diabetes can reduce the risk of heart conditions such as heart attack stroke and heart failure compared with placebo.

Drugs known as sodium-glucose cotransporter 2 (SGLT2) inhibitors are associated with a lower risk of major heart problems in patients with type 2 diabetes than dipeptidyl peptidase-4 (DPP-4) inhibitors, say, researchers. According to the study, published in the journal The BMJ, previous trials have shown that SGLT2 inhibitors can reduce the risk of heart conditions such as heart attack, stroke, and heart failure compared with placebo. But some of these trials had important limitations, making it…
-
Noosa News23 hours ago
‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
General18 hours ago
Developer warns wind energy capacity may not be ready by WA coal deadline
-
General23 hours ago
Older Aussies back increased superannuation tax
-
Noosa News20 hours ago
Tips to improve engagement – Proctor